tert-butyl (1R,3r,5S)-3-(hydroxymethyl)-9-azabicyclo[3.3.1]nonane-9-carboxylate

Catalog No. :
ACXLGT947
CAS No. :
2165429-04-7
Molecular Formula :
C14H25NO3
Molecular Weight :
255.36

IUPAC Name:tert-butyl (1R,3r,5S)-3-(hydroxymethyl)-9-azabicyclo[3.3.1]nonane-9-carboxylate

tert-butyl (1R,3r,5S)-3-(hydroxymethyl)-9-azabicyclo[3.3.1]nonane-9-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$434.00Login to see priceInquiryInquiry
250mg97%$694.00Login to see priceInquiryInquiry
1g97%$1732.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl (1R,3r,5S)-3-(hydroxymethyl)-9-azabicyclo[3.3.1]nonane-9-carboxylate
IUPAC Nametert-butyl (1R,3r,5S)-3-(hydroxymethyl)-9-azabicyclo[3.3.1]nonane-9-carboxylate
MDL No.MFCD31705601
Molecular FormulaC14H25NO3
Molecular Weight255.36
SMILESO=C(N1[C@@]2([H])C[C@H](CO)C[C@]1([H])CCC2)OC(C)(C)C
InChI KeyBEUWVRDRRLOEPZ-ZSBIGDGJSA-N
Synonymtert-butyl (1R,3r,5S)-3-(hydroxymethyl)-9-azabicyclo[3.3.1]nonane-9-carboxylate;rel-tert-butyl (1R,5S)-3-(hydroxymethyl)-9-azabicyclo[3.3.1]nonane-9-carboxylate
CAS No.2165429-04-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACXLGT947 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXLGT947 route product structure diagram
    ACXLGT9472165429-04-7
Inquiry

2. ACXLGT947 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXLGT947 route product structure diagram
    ACXLGT9472165429-04-7
Inquiry

Comments (0)